Europe gives OK to CV Therapeutics chest-pain drug(0)
CV Therapeutics said Thursday that European officials gave it the OK to market ranolazine, its treatment for patients suffering from angina, in all 27 states of the European Union. The move comes months after the European Medicines Agency gave a positive opinion Read the rest of this entry »
Subscribe via RSS all feeds